Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Al-Hashimi

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oral Diseases|January 3, 2013
Prevalence of oral lesions of autoimmune etiology in patients with primary Sjogren's syndromeK Likar-Manookin, C Stewart, I Al-Hashimi, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 1, 1997
Prevalence of periodontal disease in patients with Sjögren's syndromeM P Najera, I al-Hashimi, J M Plemons, et al.
Rheumatology (Oxford, England)|April 6, 2002
Activated caspase 3 and cleaved poly(ADP-ribose)polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjögren's syndromeF Jimenez, S Aiba-Masago, I Al Hashimi, et al.
Journal of Dental Research|February 1, 1987
Structural aspects of salivary glycoproteinsM J Levine, M S Reddy, L A Tabak, et al.
Archives of Internal Medicine|February 2, 1999
Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study GroupF B Vivino, I Al-Hashimi, Z Khan, et al.
Arthritis and Rheumatism|March 27, 2001
Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndromeR Masago, S Aiba-Masago, N Talal, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oral Diseases|January 3, 2013
Prevalence of oral lesions of autoimmune etiology in patients with primary Sjogren's syndromeK Likar-Manookin, C Stewart, I Al-Hashimi, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 1, 1997
Prevalence of periodontal disease in patients with Sjögren's syndromeM P Najera, I al-Hashimi, J M Plemons, et al.
Rheumatology (Oxford, England)|April 6, 2002
Activated caspase 3 and cleaved poly(ADP-ribose)polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjögren's syndromeF Jimenez, S Aiba-Masago, I Al Hashimi, et al.
Journal of Dental Research|February 1, 1987
Structural aspects of salivary glycoproteinsM J Levine, M S Reddy, L A Tabak, et al.
Archives of Internal Medicine|February 2, 1999
Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study GroupF B Vivino, I Al-Hashimi, Z Khan, et al.
Arthritis and Rheumatism|March 27, 2001
Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndromeR Masago, S Aiba-Masago, N Talal, et al.
Pageof 4